Evaluation of DOTS Strategy in Tuberculosis Treatment in Kirkuk Governorate

More than 2 billion people, equal to one third of the world’s population, are infected with tuberculosis (TB) bacilli, the microbes that cause TB. One in 10 people infected with TB bacilli will become sick with active TB in their lifetime. To assess treatment outcome and to evaluate the compliance of our patients registered for anti-TB treatment at Kirkuk Center of Tuberculosis Treatment. A one year prospective cohort study of tuberculosis patients (n=100) registered for anti-TB treatment at Kirkuk center of tuberculosis treatment according to the World Health Organization guidelines. Among study participants, 100 patients (100%) were sputum smear positive, the 100 study participant (100%) were tested for HIV. There was no TB-HIV co-infection .Among the 100 study participants, 90(90%) had successful treatment outcome (90 cured). The overall death, default, were 3(3%), 7 (7%) respectively. There was no treatment failure. Active pulmonary tuberculosis was predominant at age group (21-30) year, 31(31%) patients. Also there was a significant association between the residence and tuberculosis, 77 (77%) patients were living in urban area. Treatment outcome of the patients who registered in Direct Observation Treatment, Short course therapy (DOTS) was successful.